These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37594643)

  • 1. Poorly differentiated extra-axial extraskeletal chordoma diagnosed by methylation profiling: case report and analysis of brachyury expression in SWI/SNF-deficient tumors.
    Klubíčková N; Michal M; Kinkor Z; Soukup J; Ryška A; Brtková J; Lutonský M; Hájková V; Ptáková N; Michal M; Farkas M; Švajdler M
    Virchows Arch; 2024 Apr; 484(4):621-627. PubMed ID: 37594643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent loss of chromosome 22 and SMARCB1 deletion in extra-axial chordoma: A clinicopathological and molecular analysis.
    Wen X; Cimera R; Aryeequaye R; Abhinta M; Athanasian E; Healey J; Fabbri N; Boland P; Zhang Y; Hameed M
    Genes Chromosomes Cancer; 2021 Dec; 60(12):796-807. PubMed ID: 34392582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brachyury expression in intracranial SMARCB1-deficient tumors: important points for distinguishing poorly differentiated chordoma from atypical teratoid/rhabdoid tumor.
    Kohashi K; Yamamoto H; Yamada Y; Kinoshita I; Oda Y
    Hum Pathol; 2021 Jun; 112():1-8. PubMed ID: 33741347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poorly differentiated chordoma showing loss of SMARCB1/INI1: Clinicopathological and radiological spectrum of nine cases, including uncommon features of a relatively under-recognized entity.
    Rekhi B; Michal M; Ergen FB; Roy P; Puls F; Haugland HK; Soylemezoglu F; Kosemehmetoglu K
    Ann Diagn Pathol; 2021 Dec; 55():151809. PubMed ID: 34482218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic features of four rare types of chordomas, confirmed by brachyury immunostaining.
    Rekhi B; Banerjee D; Ramadwar M; Bajpai J; Jambhekar NA
    Indian J Pathol Microbiol; 2017; 60(3):350-354. PubMed ID: 28937370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pediatric SMARCB1/INI1-deficient poorly differentiated chordoma of the skull base: report of five cases and review of literature].
    Duan ZJ; Yao K; Ma Z; Hu ZJ; Xiang L; Qi XL
    Zhonghua Bing Li Xue Za Zhi; 2022 Jan; 51(1):33-38. PubMed ID: 34979751
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinicopathological features of notochordal tumors: a study of 48 cases].
    Huang J; Yang TT; Jiang ZM; Zhang HZ
    Zhonghua Bing Li Xue Za Zhi; 2021 Mar; 50(3):201-206. PubMed ID: 33677882
    [No Abstract]   [Full Text] [Related]  

  • 8. Poorly differentiated chordoma with whole-genome doubling evolving from a SMARCB1-deficient conventional chordoma: A case report.
    Curcio C; Cimera R; Aryeequaye R; Rao M; Fabbri N; Zhang Y; Hameed M
    Genes Chromosomes Cancer; 2021 Jan; 60(1):43-48. PubMed ID: 32920865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Diagnostic Pitfall: Atypical Teratoid Rhabdoid Tumor Versus Dedifferentiated/Poorly Differentiated Chordoma: Analysis of a Mono-institutional Series.
    Buccoliero AM; Caporalini C; Scagnet M; Baroni G; Moscardi S; Mussa F; Giordano F; Sardi I; Genitori L
    Appl Immunohistochem Mol Morphol; 2019 Feb; 27(2):147-154. PubMed ID: 28777153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-rhabdoid pediatric SMARCB1-deficient tumors: overlap between chordomas and malignant rhabdoid tumors?
    Renard C; Pissaloux D; Decouvelaere AV; Bourdeaut F; Ranchère D
    Cancer Genet; 2014 Sep; 207(9):384-9. PubMed ID: 25053104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of SMARCB1/INI1 expression in poorly differentiated chordomas.
    Mobley BC; McKenney JK; Bangs CD; Callahan K; Yeom KW; Schneppenheim R; Hayden MG; Cherry AM; Gokden M; Edwards MS; Fisher PG; Vogel H
    Acta Neuropathol; 2010 Dec; 120(6):745-53. PubMed ID: 21057957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poorly differentiated chordoma with loss of SMARCB1/INI1 expression in pediatric patients: A report of two cases and review of the literature.
    Cha YJ; Hong CK; Kim DS; Lee SK; Park HJ; Kim SH
    Neuropathology; 2018 Feb; 38(1):47-53. PubMed ID: 28812319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SMARCB1-deficient Tumors of Childhood: A Practical Guide.
    Pawel BR
    Pediatr Dev Pathol; 2018; 21(1):6-28. PubMed ID: 29280680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extra-axial chordoma of the thumb: Report of a rare case with clinicopathologic and molecular analysis.
    Tehrani SG; Kaltoft NS; Melchior LC; Loya AC
    Pathol Res Pract; 2021 Sep; 225():153564. PubMed ID: 34340129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extra-axial soft tissue chordoma of wrist.
    Suzuki H; Yamashiro K; Takeda H; Nojima T; Usui M
    Pathol Res Pract; 2011 May; 207(5):327-31. PubMed ID: 21397407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extra-axial chordoma: a clinicopathologic analysis of six cases.
    Righi A; Sbaraglia M; Gambarotti M; Cocchi S; Drago G; Casadei R; Picci P; Vanel D; Dei Tos AP
    Virchows Arch; 2018 Jun; 472(6):1015-1020. PubMed ID: 29560513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosing an extra-axial chordoma of the proximal tibia with the help of brachyury, a molecule required for notochordal differentiation.
    O'donnell P; Tirabosco R; Vujovic S; Bartlett W; Briggs TW; Henderson S; Boshoff C; Flanagan AM
    Skeletal Radiol; 2007 Jan; 36(1):59-65. PubMed ID: 16810540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity of brachyury in the distinction of chordoma from clear cell renal cell carcinoma and germ cell tumors: a study of 305 cases.
    Sangoi AR; Karamchandani J; Lane B; Higgins JP; Rouse RV; Brooks JD; McKenney JK
    Mod Pathol; 2011 Mar; 24(3):425-9. PubMed ID: 21102418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SWI/SNF complex-deficient soft tissue neoplasms: An update.
    Schaefer IM; Hornick JL
    Semin Diagn Pathol; 2021 May; 38(3):222-231. PubMed ID: 32646614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The genetic landscape of SMARCB1 alterations in SMARCB1-deficient spectrum of mesenchymal neoplasms.
    Dermawan JK; Singer S; Tap WD; Nacev BA; Chi P; Wexler LH; Ortiz MV; Gounder M; Antonescu CR
    Mod Pathol; 2022 Dec; 35(12):1900-1909. PubMed ID: 36088476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.